With the addition of 247 pilot study participants recruited between 1999 and 2001 , 2664 men were eligible for the treatment trial and 1643 ( 62 % ) agreed to be randomly assigned ( 545 to active monitoring , 545 to radiotherapy , and 553 to radical prostatectomy ) .